Your browser doesn't support javascript.
loading
Recent Advances in Pyrimidine-Based Drugs.
Nammalwar, Baskar; Bunce, Richard A.
Afiliação
  • Nammalwar B; Vividion Therapeutics, 5820 Nancy Ridge Drive, San Diego, CA 92121, USA.
  • Bunce RA; Department of Chemistry, Oklahoma State University, Stillwater, OK 74078, USA.
Pharmaceuticals (Basel) ; 17(1)2024 Jan 11.
Article em En | MEDLINE | ID: mdl-38256937
ABSTRACT
Pyrimidines have become an increasingly important core structure in many drug molecules over the past 60 years. This article surveys recent areas in which pyrimidines have had a major impact in drug discovery therapeutics, including anti-infectives, anticancer, immunology, immuno-oncology, neurological disorders, chronic pain, and diabetes mellitus. The article presents the synthesis of the medicinal agents and highlights the role of the biological target with respect to the disease model. Additionally, the biological potency, ADME properties and pharmacokinetics/pharmacodynamics (if available) are discussed. This survey attempts to demonstrate the versatility of pyrimidine-based drugs, not only for their potency and affinity but also for the improved medicinal chemistry properties of pyrimidine as a bioisostere for phenyl and other aromatic π systems. It is hoped that this article will provide insight to researchers considering the pyrimidine scaffold as a chemotype in future drug candidates in order to counteract medical conditions previously deemed untreatable.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2024 Tipo de documento: Article